Sequana Medical receives CE-mark approval for the use of its alfapump® system in cancer patients with malignant ascites

30 October 2012

Innovative implantable pump system set to benefit patients with ascites caused by cancer..

Read more

Sequana Medical nominated for Swiss Technology Award 2012

14 September 2012

Sequana Medical has been nominated as a finalist in the 'maturity stage' category of the Swiss Technology Award 2012.

Read more

University Hospital Zurich and University Inselspital Berne implant their first patients with Sequana Medical’s alfapump® System

23 May 2012

Swiss company’s innovative technology for the management of refractory ascites significantly reduces the need for large-volume paracentesis, improving patient quality of life...

Read more

Sequana Medical’s alfapump® system proves to be a safe and efficacious breakthrough technology in ascites management

20 April 2012

Data presented at the International Liver Disease Meeting demonstrated that the alfapump system significantly decreases the need for Large Volume Paracentesis and can reduce hospital visit...

Read more

Sequana Medical’s alfapump® system receives reimbursement in Germany for breakthrough technology in ascites management

1 March 2012

NUB grants approval for fifteen leading hepatology centres in Germany.

Read more

Sequana Medical has been selected as a finalist for the 2012 MEDTEC EMDT Innovation Awards

30 January 2012

Sequana Medical from Zürich, Switzerland has been nominated for one of the European medical-device industry’s most prestigious awards...

Read more

NHS National Innovation Centre estimates Sequana Medical’s alfapump® system could save the NHS £50 million in ascites care annually

9 December 2011

NHS National Innovation Centre supports the cost effectiveness of Sequana Medical’s ALFApump System.

Read more

First Commerical Implants

4 November 2011

The Medical University of Vienna and Vienna General Hospital perform the first two commercial implants worldwide of Sequana Medical’s alfapump system.

Read more

Sequana Medical receives CE Mark Approval for the alfapump® system and adds Key Executive to Team

13 July 2011

New technology expands treatment options for patient with refractory ascites due to liver cirrhosis.

Read more

NovaShunt announces the launch of its new corporate identity: Sequana Medical

30 May 2011

NovaShunt AG has launched a new corporate identity and product branding to support its goal of leadership in the area of fluid management within the body. The company will now operate as Sequana Medical AG ( as it prepares for the upcoming launch of the alfapump system in Europe.

Read more